Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Profit After Tax (2021 - 2025)

Historic Profit After Tax for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$2.4 million.

  • HeartSciences' Profit After Tax fell 1285.94% to -$2.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$9.0 million, marking a year-over-year decrease of 1851.65%. This contributed to the annual value of -$8.8 million for FY2025, which is 3270.18% down from last year.
  • HeartSciences' Profit After Tax amounted to -$2.4 million in Q4 2025, which was down 1285.94% from -$2.1 million recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Profit After Tax registered a high of -$501851.0 during Q3 2021, and its lowest value of -$2.5 million during Q1 2025.
  • Its 5-year average for Profit After Tax is -$1.7 million, with a median of -$1.8 million in 2022.
  • Per our database at Business Quant, HeartSciences' Profit After Tax tumbled by 21350.0% in 2022 and then surged by 2049.43% in 2023.
  • Quarter analysis of 5 years shows HeartSciences' Profit After Tax stood at -$1.0 million in 2021, then tumbled by 74.58% to -$1.8 million in 2022, then increased by 3.22% to -$1.7 million in 2023, then decreased by 19.13% to -$2.1 million in 2024, then dropped by 12.86% to -$2.4 million in 2025.
  • Its Profit After Tax was -$2.4 million in Q4 2025, compared to -$2.1 million in Q3 2025 and -$2.1 million in Q2 2025.